+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Asia-Pacific Radiation Oncology Market Size, Share & Trends Analysis Report by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), Technology, Application, Country, and Segment Forecasts, 2025-2030

  • PDF Icon

    Report

  • 90 Pages
  • October 2024
  • Region: Asia Pacific
  • Grand View Research
  • ID: 6024575
The Asia Pacific radiation oncology market size is expected to reach USD 4.02 billion in 2030 and is projected to grow at a CAGR of 11.6% from 2025 to 2030. Technological advancements in radiation therapy over the years is one of the key factors responsible for market growth.

Advancements in computers have resulted in faster, smarter, and more capable treatment planning and have enabled constant imaging guidance, more precise dosing, and delivery of higher doses. This has resulted in greater efficiency and lesser adverse effects. For instance, in April 2018, Manipal Hospitals in India introduced brachytherapy facilities for the treatment of gynecologic cancers, including endometrial and cervical cancers. In addition, major key players are increasingly focusing on the development and launch of new and innovative brachytherapy products.

Furthermore, rising strategic initiatives by hospitals and key players to adopt new technologies are expected to boost market growth. For instance, in May 2019, Accuray, Inc. entered into an agreement with Hong Kong Sanatorium and Hospital (HKSH) for the acquisition of two Synchrony motion tracking and correction technology to be used with Radixact Systems.

In addition, increasing approval by regulatory bodies to enhance access to advanced radiation therapy for patients and clinicians is anticipated to drive the market. For instance, in March 2020, Varian received approval from the China National Medical Products Administration (NMPA) for the Halcyon 2.0 treatment system.

The rising installation of new radiotherapy systems in hospitals by manufacturers is anticipated to accelerate market growth. For instance, in June 2019, Varian installed the ProBeam Compact single-room proton therapy system for Cyclotron at King Chulalongkorn Memorial Hospital in Thailand.

An increasing number of proton centers to combat the rising demand for accurate and effective radiation therapy technologies is anticipated to boost the market over the forecast period. For instance, in January 2019, IBA opened Apollo Proton Cancer Centre in India to treat patients with proton therapy systems such as Proteus PLUS.

Elekta AB and Accuray Incorporated are expected to hold a majority of share in the market over the forecast period. Elekta AB is geographically expanding in markets outside China and an increasing number of installed units are expected to reach the end of the life cycle, further requiring replacements, service, and support. Furthermore, Accuray Incorporated is focusing on strategic collaborations to attain a high market share. For instance, in January 2019, Accuray Asia collaborated with China Isotope and Radiation Corporation’s wholly-owned subsidiary, CNNC High Energy Equipment (Tianjin) Co., Ltd. to develop and sell radiation oncology systems in China.

Asia Pacific Radiation Oncology Market Report Highlights

  • External beam radiation therapy (EBRT) dominated the market with a revenue share of 35.9% in 2024.
  • Internal beam radiation therapy is expected to grow at the fastest CAGR of 16.5% over the forecast period.
  • Applications in breast cancer under the EBRT segment led the market with 26.3% of the total revenue share in 2024, driven by EBRT’s effectiveness, increased awareness, and early detection initiatives.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments
  • Competitive Landscape: Explore the market presence of key players worldwide
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

The leading players in the Asia-Pacific Radiation Oncology market include:

  • NTP Radioisotopes SOC Ltd
  • Varian Medical Systems, Inc.
  • Nordion Inc.
  • Mevion Medical Systems
  • Perspecitve Therapeutics Inc.
  • Accuray Incorporated
  • BD
  • IBA Radiopharma Solutions
  • Elekta
  • Curium


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Technology
1.2.3. Application
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Asia Pacific Radiation Oncology Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Asia Pacific Radiation Oncology Market: Type Business Analysis
4.1. Type Market Share, 2024 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. External Beam Radiation Therapy
4.4.1. External Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
4.4.2. Electron-Emitting High-Energy Linear Accelerators (Linac)
4.4.2.1. Electron-Emitting High-Energy Linear Accelerators (Linac) Market, 2018 - 2030 (USD Million)
4.4.3. MRI LINACs
4.4.3.1. MRI LINACs Market, 2018 - 2030 (USD Million)
4.4.4. Compact Advanced Radiotherapy Systems
4.4.4.1. Compact Advanced Radiotherapy Systems Market, 2018 - 2030 (USD Million)
4.4.4.2. Cyberknife
4.4.4.2.1. Cyberknife Market, 2018 - 2030 (USD Million)
4.4.4.3. Gamma Knife
4.4.4.3.1. Gamma Knife Market, 2018 - 2030 (USD Million)
4.4.4.4. Tomotherapy
4.4.4.4.1. Tomotherapy Market, 2018 - 2030 (USD Million)
4.4.5. Proton Therapy
4.4.5.1. Proton Therapy Market, 2018 - 2030 (USD Million)
4.4.5.2. Cyclotron
4.4.5.2.1. Cyclotron Market, 2018 - 2030 (USD Million)
4.4.5.3. Synchrotron
4.4.5.3.1. Synchrotron Market, 2018 - 2030 (USD Million)
4.5. Internal Beam Radiation Therapy
4.5.1. Internal Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
4.5.2. Brachytherapy
4.5.2.1. Brachytherapy Market, 2018 - 2030 (USD Million)
4.5.2.2. Seeds
4.5.2.2.1. Seeds Market, 2018 - 2030 (USD Million)
4.5.2.3. Applicators and Afterloaders
4.5.2.3.1. Applicators and Afterloaders Market, 2018 - 2030 (USD Million)
4.5.2.4. Electronic Brachytherapy
4.5.2.4.1. Electronic Brachytherapy Market, 2018 - 2030 (USD Million)
4.5.3. Systemic Beam Radiation Therapy
4.5.3.1. Systemic Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
4.5.4. Others
4.5.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Asia Pacific Radiation Oncology Market: Technology Business Analysis
5.1. Technology Market Share, 2024 & 2030
5.2. Technology Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. External Beam Radiation Therapy
5.4.1. External Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
5.4.2. Image-Guided Radiotherapy (IGRT)
5.4.2.1. Image-Guided Radiotherapy (IGRT) Market, 2018 - 2030 (USD Million)
5.4.3. Intensity Modulated Radiotherapy (IMRT)
5.4.3.1. Intensity Modulated Radiotherapy (IMRT) Market, 2018 - 2030 (USD Million)
5.4.4. Stereotactic Technology
5.4.4.1. Stereotactic Technology Market, 2018 - 2030 (USD Million)
5.4.5. Proton Beam Therapy
5.4.5.1. Proton Beam Therapy Market, 2018 - 2030 (USD Million)
5.4.6. 3D Conformal Radiotherapy (3D CRT)
5.4.6.1. 3D Conformal Radiotherapy (3D CRT) Market, 2018 - 2030 (USD Million)
5.4.7. Volumetric Modulated Arc Therapy (VMAT)
5.4.7.1. Volumetric Modulated Arc Therapy (VMAT) Market, 2018 - 2030 (USD Million)
5.5. Brachytherapy
5.5.1. Brachytherapy Market, 2018 - 2030 (USD Million)
5.5.2. HDR Brachytherapy
5.5.2.1. HDR Brachytherapy Market, 2018 - 2030 (USD Million)
5.5.3. LDR Brachytherapy
5.5.3.1. LDR Brachytherapy Market, 2018 - 2030 (USD Million)
Chapter 6. Asia Pacific Radiation Oncology Market: Application Business Analysis
6.1. Application Market Share, 2024 & 2030
6.2. Application Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. External Beam Radiation Therapy
6.4.1. External Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
6.4.2. Prostate Cancer
6.4.2.1. Prostate Cancer Market, 2018 - 2030 (USD Million)
6.4.3. Breast Cancer
6.4.3.1. Breast Cancer Market, 2018 - 2030 (USD Million)
6.4.4. Lung Cancer
6.4.4.1. Lung Cancer Market, 2018 - 2030 (USD Million)
6.4.5. Head and Neck Cancer
6.4.5.1. Head and Neck Cancer Market, 2018 - 2030 (USD Million)
6.4.6. Colorectal Cancer
6.4.6.1. Colorectal Cancer Market, 2018 - 2030 (USD Million)
6.4.7. Others
6.4.7.1. Others Market, 2018 - 2030 (USD Million)
6.5. Internal Beam Radiation Therapy
6.5.1. Internal Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
6.5.2. Prostate Cancer
6.5.2.1. Prostate Cancer Market, 2018 - 2030 (USD Million)
6.5.3. Gynecological Cancer
6.5.3.1. Gynecological Cancer Market, 2018 - 2030 (USD Million)
6.5.4. Breast Cancer
6.5.4.1. Breast Cancer Market, 2018 - 2030 (USD Million)
6.5.5. Cervical Cancer
6.5.5.1. Cervical Cancer Market, 2018 - 2030 (USD Million)
6.5.6. Penile Cancer
6.5.6.1. Penile Cancer Market, 2018 - 2030 (USD Million)
6.5.7. Others
6.5.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Asia Pacific Radiation Oncology Market: Country Estimates & Trend Analysis by Type, Technology, and Application
7.1. Country Market Share Analysis, 2024 & 2030
7.2. Country Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. Japan
7.4.1. Key Country Dynamics
7.4.2. Regulatory Framework
7.4.3. Competitive Insights
7.4.4. Japan Radiation Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5. China
7.5.1. Key Country Dynamics
7.5.2. Regulatory Framework
7.5.3. Competitive Insights
7.5.4. China Radiation Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6. India
7.6.1. Key Country Dynamics
7.6.2. Regulatory Framework
7.6.3. Competitive Insights
7.6.4. India Radiation Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.7. South Korea
7.7.1. Key Country Dynamics
7.7.2. Regulatory Framework
7.7.3. Competitive Insights
7.7.4. South Korea Radiation Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.8. Australia
7.8.1. Key Country Dynamics
7.8.2. Regulatory Framework
7.8.3. Competitive Insights
7.8.4. Australia Radiation Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.9. Singapore
7.9.1. Key Country Dynamics
7.9.2. Regulatory Framework
7.9.3. Competitive Insights
7.9.4. Singapore Radiation Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.10. New Zealand
7.10.1. Key Country Dynamics
7.10.2. Regulatory Framework
7.10.3. Competitive Insights
7.10.4. New Zealand Radiation Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.11. Malaysia
7.11.1. Key Country Dynamics
7.11.2. Regulatory Framework
7.11.3. Competitive Insights
7.11.4. Malaysia Radiation Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.12. Thailand
7.12.1. Key Country Dynamics
7.12.2. Regulatory Framework
7.12.3. Competitive Insights
7.12.4. Thailand Radiation Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.13. Indonesia
7.13.1. Key Country Dynamics
7.13.2. Regulatory Framework
7.13.3. Competitive Insights
7.13.4. Indonesia Radiation Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.14. Vietnam
7.14.1. Key Country Dynamics
7.14.2. Regulatory Framework
7.14.3. Competitive Insights
7.14.4. Vietnam Radiation Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. NTP Radioisotopes SOC Ltd
8.5.1.1. Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Varian Medical Systems, Inc.
8.5.2.1. Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Nordion Inc.
8.5.3.1. Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Mevion Medical Systems
8.5.4.1. Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Perspecitve Therapeutics Inc.
8.5.5.1. Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Accuray Incorporated
8.5.6.1. Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. BD
8.5.7.1. Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. IBA Radiopharma Solutions
8.5.8.1. Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. Elekta
8.5.9.1. Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Curium
8.5.10.1. Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Asia Pacific radiation oncology market, by country, 2018 - 2030 (USD Million)
Table 4. Asia Pacific radiation oncology market, by drug class, 2018 - 2030 (USD Million)
Table 5. Asia Pacific radiation oncology market, by route of administration, 2018 - 2030 (USD Million)
Table 6. Asia Pacific radiation oncology market, by distribution channel, 2018 - 2030 (USD Million)
Table 7. Japan Asia Pacific radiation oncology market, by type, 2018 - 2030 (USD Million)
Table 8. Japan Asia Pacific radiation oncology market, by technology, 2018 - 2030 (USD Million)
Table 9. Japan Asia Pacific radiation oncology market, by application, 2018 - 2030 (USD Million)
Table 10. China Asia Pacific radiation oncology market, by type, 2018 - 2030 (USD Million)
Table 11. China Asia Pacific radiation oncology market, by technology, 2018 - 2030 (USD Million)
Table 12. China Asia Pacific radiation oncology market, by application, 2018 - 2030 (USD Million)
Table 13. India Asia Pacific radiation oncology market, by type, 2018 - 2030 (USD Million)
Table 14. India Asia Pacific radiation oncology market, by technology, 2018 - 2030 (USD Million)
Table 15. India Asia Pacific radiation oncology market, by application, 2018 - 2030 (USD Million)
Table 16. South Korea Asia Pacific radiation oncology market, by type, 2018 - 2030 (USD Million)
Table 17. South Korea Asia Pacific radiation oncology market, by technology, 2018 - 2030 (USD Million)
Table 18. South Korea Asia Pacific radiation oncology market, by application, 2018 - 2030 (USD Million)
Table 19. Australia Asia Pacific radiation oncology market, by type, 2018 - 2030 (USD Million)
Table 20. Australia Asia Pacific radiation oncology market, by technology, 2018 - 2030 (USD Million)
Table 21. Australia Asia Pacific radiation oncology market, by application, 2018 - 2030 (USD Million)
Table 22. Singapore Asia Pacific radiation oncology market, by type, 2018 - 2030 (USD Million)
Table 23. Singapore Asia Pacific radiation oncology market, by technology, 2018 - 2030 (USD Million)
Table 24. Singapore Asia Pacific radiation oncology market, by application, 2018 - 2030 (USD Million)
Table 25. New Zealand Asia Pacific radiation oncology market, by type, 2018 - 2030 (USD Million)
Table 26. New Zealand Asia Pacific radiation oncology market, by technology, 2018 - 2030 (USD Million)
Table 27. New Zealand Asia Pacific radiation oncology market, by application, 2018 - 2030 (USD Million)
Table 28. Malaysia Asia Pacific radiation oncology market, by type, 2018 - 2030 (USD Million)
Table 29. Malaysia Asia Pacific radiation oncology market, by technology, 2018 - 2030 (USD Million)
Table 30. Malaysia Asia Pacific radiation oncology market, by application, 2018 - 2030 (USD Million)
Table 31. Thailand Asia Pacific radiation oncology market, by type, 2018 - 2030 (USD Million)
Table 32. Thailand Asia Pacific radiation oncology market, by technology, 2018 - 2030 (USD Million)
Table 33. Thailand Asia Pacific radiation oncology market, by application, 2018 - 2030 (USD Million)
Table 34. Indonesia Asia Pacific radiation oncology market, by type, 2018 - 2030 (USD Million)
Table 35. Indonesia Asia Pacific radiation oncology market, by technology, 2018 - 2030 (USD Million)
Table 36. Indonesia Asia Pacific radiation oncology market, by application, 2018 - 2030 (USD Million)
Table 37. Vietnam Asia Pacific radiation oncology market, by type, 2018 - 2030 (USD Million)
Table 38. Vietnam Asia Pacific radiation oncology market, by technology, 2018 - 2030 (USD Million)
Table 39. Vietnam Asia Pacific radiation oncology market, by application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Asia Pacific radiation oncology market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Type and technology outlook
Fig. 10 Application outlook
Fig. 11 Competitive landscape
Fig. 12 Asia Pacific radiation oncology market dynamics
Fig. 13 Asia Pacific radiation oncology market: Porter’s five forces analysis
Fig. 14 Asia Pacific radiation oncology market: PESTLE analysis
Fig. 15 Asia Pacific radiation oncology market: Type segment dashboard
Fig. 16 Asia Pacific radiation oncology market: Type market share analysis, 2024 & 2030
Fig. 17 External beam radiation therapy market, 2018 - 2030 (USD Million)
Fig. 18 Electron-emitting high-energy linear accelerators (linac) market, 2018 - 2030 (USD Million)
Fig. 19 MRI LINACs market, 2018 - 2030 (USD Million)
Fig. 20 Compact advanced radiotherapy systems market, 2018 - 2030 (USD Million)
Fig. 21 Cyberknife market, 2018 - 2030 (USD Million)
Fig. 22 Gamma knife market, 2018 - 2030 (USD Million)
Fig. 23 Tomotherapy market, 2018 - 2030 (USD Million)
Fig. 24 Proton therapy market, 2018 - 2030 (USD Million)
Fig. 25 Cyclotron market, 2018 - 2030 (USD Million)
Fig. 26 Synchrotron market, 2018 - 2030 (USD Million)
Fig. 27 Internal beam radiation therapy market, 2018 - 2030 (USD Million)
Fig. 28 Brachytherapy market, 2018 - 2030 (USD Million)
Fig. 29 Seeds market, 2018 - 2030 (USD Million)
Fig. 30 Applicators and afterloaders market, 2018 - 2030 (USD Million)
Fig. 31 Electronic brachytherapy market, 2018 - 2030 (USD Million)
Fig. 32 Systemic beam radiation therapy market, 2018 - 2030 (USD Million)
Fig. 33 Others market, 2018 - 2030 (USD Million)
Fig. 34 Asia Pacific radiation oncology market: Technology segment dashboard
Fig. 35 Asia Pacific radiation oncology market: Technology market share analysis, 2024 & 2030
Fig. 36 External beam radiation therapy market, 2018 - 2030 (USD Million)
Fig. 37 Image-guided radiotherapy (IGRT) market, 2018 - 2030 (USD Million)
Fig. 38 Intensity modulated radiotherapy (IMRT) market, 2018 - 2030 (USD Million)
Fig. 39 Stereotactic technology market, 2018 - 2030 (USD Million)
Fig. 40 Proton Beam therapy market, 2018 - 2030 (USD Million)
Fig. 41 3D conformal radiotherapy (3D CRT) market, 2018 - 2030 (USD Million)
Fig. 42 Volumetric modulated arc therapy (VMAT) market, 2018 - 2030 (USD Million)
Fig. 43 Brachytherapy market, 2018 - 2030 (USD Million)
Fig. 44 HDR brachytherapy market, 2018 - 2030 (USD Million)
Fig. 45 LDR brachytherapy market, 2018 - 2030 (USD Million)
Fig. 46 Asia Pacific radiation oncology market: Application segment dashboard
Fig. 47 Asia Pacific radiation oncology market: Application market share analysis, 2024 & 2030
Fig. 48 External beam radiation therapy market, 2018 - 2030 (USD Million)
Fig. 49 Prostate cancer market, 2018 - 2030 (USD Million)
Fig. 50 Breast cancer market, 2018 - 2030 (USD Million)
Fig. 51 Lung cancer market, 2018 - 2030 (USD Million)
Fig. 52 Head and neck cancer market, 2018 - 2030 (USD Million)
Fig. 53 Colorectal cancer market, 2018 - 2030 (USD Million)
Fig. 54 Others market, 2018 - 2030 (USD Million)
Fig. 55 Internal beam radiation therapy market, 2018 - 2030 (USD Million)
Fig. 56 Prostate cancer market, 2018 - 2030 (USD Million)
Fig. 57 Gynecological cancer market, 2018 - 2030 (USD Million)
Fig. 58 Breast cancer market, 2018 - 2030 (USD Million)
Fig. 59 Cervical cancer market, 2018 - 2030 (USD Million)
Fig. 60 Penile cancer market, 2018 - 2030 (USD Million)
Fig. 61 Others market, 2018 - 2030 (USD Million)
Fig. 62 Asia Pacific radiation oncology market revenue, by country
Fig. 63 Country marketplace: Key takeaways
Fig. 64 Country marketplace: Key takeaways
Fig. 65 Japan country dynamics
Fig. 66 Japan radiation oncology market, 2018 - 2030 (USD Million)
Fig. 67 China country dynamics
Fig. 68 China radiation oncology market, 2018 - 2030 (USD Million)
Fig. 69 India country dynamics
Fig. 70 India radiation oncology market, 2018 - 2030 (USD Million)
Fig. 71 South Korea country dynamics
Fig. 72 South Korea radiation oncology market, 2018 - 2030 (USD Million)
Fig. 73 Australia country dynamics
Fig. 74 Australia radiation oncology market, 2018 - 2030 (USD Million)
Fig. 75 Singapore country dynamics
Fig. 76 Singapore radiation oncology market, 2018 - 2030 (USD Million)
Fig. 77 New Zealand country dynamics
Fig. 78 New Zealand radiation oncology market, 2018 - 2030 (USD Million)
Fig. 79 Malaysia country dynamics
Fig. 80 Malaysia radiation oncology market, 2018 - 2030 (USD Million)
Fig. 81 Thailand country dynamics
Fig. 82 Thailand radiation oncology market, 2018 - 2030 (USD Million)
Fig. 83 Indonesia country dynamics
Fig. 84 Indonesia radiation oncology market, 2018 - 2030 (USD Million)
Fig. 85 Vietnam country dynamics
Fig. 86 Vietnam radiation oncology market, 2018 - 2030 (USD Million)
Fig. 87 Company categorization
Fig. 88 Company market position analysis
Fig. 89 Strategic framework

Companies Mentioned

  • NTP Radioisotopes SOC Ltd
  • Varian Medical Systems, Inc.
  • Nordion Inc.
  • Mevion Medical Systems
  • Perspecitve Therapeutics Inc.
  • Accuray Incorporated
  • BD
  • IBA Radiopharma Solutions
  • Elekta
  • Curium

Methodology

Loading
LOADING...

Table Information